Section Navigation

News rss icon

  • No categories

Using pain-related brain activity to improve pain relief in infants

Researchers have developed a non-invasive means to measure pain-related brain activity, which could help to reduce pain in babies undergoing medical procedures. One of the major challenges to assessing and managing pain in very young children is that they are unable to articulate their feelings. Instead, paediatricians rely on observations of facial expressions or heart […]

Oxford student creates first synthetic retina

A synthetic, soft tissue retina developed by an Oxford University student could offer fresh hope to visually impaired people. Until now, all artificial retinal research has used only rigid, hard materials. The new research, by Vanessa Restrepo-Schild, a 24-year-old doctoral student and researcher at Oxford University’s Department of Chemistry, is the first to successfully use biological, […]

Antibody genes influence forgotten heart disease

New research has found that genetic differences in antibody genes alter individuals’ susceptibility to rheumatic heart disease, a forgotten inflammatory heart condition – known as ‘RHD’ – that is rife in developing countries. Rheumatic heart disease is triggered by bacterial sore throat or skin infection during childhood. The disease causes the heart valves to stiffen […]

Single cell focus reveals hidden cancer cells

Researchers have found a way to identify rogue cancer cells which survive treatment after the rest of the tumour is destroyed, by using a new technique that enables them to identify and characterise individual cancer cells. Recent breakthroughs are revolutionising cancer treatment, enabling doctors to personalise chemotherapy for each patient. However, although these new treatments […]

World’s largest health big data institute opens in Oxford

A new £115 million biomedical research centre will pave the way for treatments for some of the biggest population health issues around the globe, potentially improving the everyday lives of millions. Opened with the support of a £20m gift from the Li Ka Shing Foundation, the centre will bring together researchers from related teams to […]

Public invited to help tackle antibiotic resistance

An online project has been launched to study antibiotic resistance in Tuberculosis (TB) with the help of the public. The project website, bashthebug.net, shows volunteers images of a series of small, circular wells, each containing M.tuberculosis (the bug that causes TB) and a different dose of an antibiotic. The users are then asked to identify […]

New Associate R&D Director – Oxford Health NHS Foundation Trust

Professor Andrea Cipriani is the Oxford Health NHS Foundation Trust’s new Associate R&D Director. Professor Cipriani is a senior clinical researcher at the Department of Psychiatry at Oxford University, and honorary consultant psychiatrist at the Trust. His field of expertise in research is evidence synthesis and clinical trials, with a special focus on the evaluation […]

New potential treatment target for inflammatory bowel disease patients

A new study could change the lives of millions of people living with inflammatory bowel diseases (IBD) who don’t respond to the current standard of care. Researchers at the Kennedy Institute of Rheumatology and Translational Gastroenterology Unit, University of Oxford have identified a potential therapeutic target for IBD. The findings are of particular importance to […]

Ebola vaccine offers long-lasting immunity

An Ebola vaccine has been shown to provide immunity for up to a year after immunisation in all of those immunised in a new study. The study was led by the Oxford Vaccine Group at the University of Oxford. It tested the prime-boost Ebola vaccine regimen being developed by Janssen Vaccines & Prevention B.V. that […]

New trial for blindness rewrites the genetic code

Researchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people. Retinitis pigmentosa is currently untreatable and leads to a slow and irreversible loss of vision. For the full story on University of Oxford website

Copyright 2017 © Oxford Academic Health Science Centre